challenge: What is a potential therapeutic approach for B-cell acute lymphoblastic leukemia with SH2B3 gene mutations?
  
  A. Inhibiting the JAK/STAT signaling pathway
  B. Targeting the interleukin-7 signaling pathway
  C. Enhancing the expression of LNK
  D. Promoting the expansion of pre B-cell progenitors
  Answer: 